Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome
- PMID: 1922799
- DOI: 10.1212/wnl.41.10.1588
Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome
Abstract
Stiff-man syndrome is a rare disorder of unknown etiology in which progressive rigidity, spasms, and continuous motor unit activity may be due to dysfunction of GABAergic inhibition of alpha motor neurons. Some patients with this disorder have evidence of autoantibodies reactive with glutamic acid decarboxylase (GAD). We describe a patient with progressive stiff-man syndrome and high titers of GAD-like immunoreactivity in serum but not spinal fluid. Plasmapheresis resulted in lowered antibody titers, decreased exteroceptive reflex responses, reduced motor unit activity, and marked clinical improvement. Immunohistochemistry using patient serum and plasma produced specific labeling of human and experimental animal tissue consistent with GABAergic neurons and terminal fields. This antibody response was not present in samples from more than 200 other patients. These results provide additional evidence of an autoimmune mechanism for stiff-man syndrome and indicate plasmapheresis may be beneficial in some patients.
Similar articles
-
[Marked clinical improvement by plasmapheresis in a patient with stiff-man syndrome: a case with a negative anti-GAD antibody].Rinsho Shinkeigaku. 1995 Aug;35(8):897-900. Rinsho Shinkeigaku. 1995. PMID: 8665734 Review. Japanese.
-
Stiff-man syndrome revisited.South Med J. 1995 Aug;88(8):805-8. doi: 10.1097/00007611-199508000-00002. South Med J. 1995. PMID: 7631203 Review.
-
Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome.N Engl J Med. 1990 May 31;322(22):1555-60. doi: 10.1056/NEJM199005313222202. N Engl J Med. 1990. PMID: 2135382
-
Stiff-leg syndrome: a focal form of stiff-man syndrome.Ann Neurol. 1998 Mar;43(3):400-3. doi: 10.1002/ana.410430322. Ann Neurol. 1998. PMID: 9506561
-
Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.Ann Neurol. 1998 Aug;44(2):194-201. doi: 10.1002/ana.410440209. Ann Neurol. 1998. PMID: 9708541
Cited by
-
Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes.Muscle Nerve. 2012 May;45(5):623-34. doi: 10.1002/mus.23234. Muscle Nerve. 2012. PMID: 22499087 Free PMC article. Review.
-
Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions.BMC Health Serv Res. 2022 Jul 12;22(1):904. doi: 10.1186/s12913-022-08210-z. BMC Health Serv Res. 2022. PMID: 35831856 Free PMC article.
-
Stiff man syndrome.CNS Drugs. 2001;15(7):515-26. doi: 10.2165/00023210-200115070-00002. CNS Drugs. 2001. PMID: 11510622 Review.
-
Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome.J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):395-7. doi: 10.1136/jnnp.62.4.395. J Neurol Neurosurg Psychiatry. 1997. PMID: 9120459 Free PMC article. Clinical Trial.
-
Neurophysiological Insights into the Pathophysiology of Stiff-Person Spectrum Disorders.Mov Disord Clin Pract. 2025 Apr;12(4):409-417. doi: 10.1002/mdc3.14328. Epub 2025 Jan 8. Mov Disord Clin Pract. 2025. PMID: 39778012 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources